Vidaza azacitidine: Phase I/II data

Data from a Phase I/II trial of Vidaza plus all-trans retinoic acid (ATRA) and valproic acid (VPA) in 16 evaluable MDS and AML patients showed that one patient had a complete response (CR), 2 patients...